We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+5.4%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$3.28B
AUM Growth
-$25.4M
Cap. Flow
-$180M
Cap. Flow %
-5.48%
Top 10 Hldgs %
37.75%
Holding
50
New
1
Increased
6
Reduced
37
Closed
1

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$104M
2
AMGN icon
Amgen
AMGN
+$40M
3
TE
TECO ENERGY INC
TE
+$5.62M
4
PM icon
Philip Morris
PM
+$5.32M
5
SO icon
Southern Company
SO
+$4.29M

Top Sells

Rank Stock Value
1
NEE icon
NextEra Energy
NEE
+$126M
2
ABBV icon
AbbVie
ABBV
+$49M
3
CELG
Celgene Corp
CELG
+$15.1M
4
DD icon
DuPont de Nemours
DD
+$10.2M
5
TMO icon
Thermo Fisher Scientific
TMO
+$9.91M

Sector Composition

Rank Sector Weight
1 Healthcare 19.07%
2 Industrials 14.74%
3 Technology 13.46%
4 Energy 11.66%
5 Utilities 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
26
Microsoft
MSFT
$3.66T
$86.1M 2.63%
2,588,325
-121,102
-4% -$3.98M
CSCO icon
27
Cisco
CSCO
$488B
$85.8M 2.61%
3,659,759
-201,922
-5% -$5.01M
QCOM icon
28
Qualcomm
QCOM
$171B
$83.7M 2.55%
1,243,737
-55,738
-4% -$3.65M
ORCL icon
29
Oracle
ORCL
$442B
$79.7M 2.43%
2,403,939
-92,887
-4% -$3.01M
AMGN icon
30
Amgen
AMGN
$225B
$41.3M 1.26%
+368,873
New +$40M
ABT icon
31
Abbott
ABT
$192B
$38.6M 1.18%
1,163,008
-48,806
-4% -$1.71M
MDLZ icon
32
Mondelez International
MDLZ
$79.4B
$10.3M 0.31%
326,250
-22,100
-6% -$686K
TE
33
DELISTED
TECO ENERGY INC
TE
$9.76M 0.3%
590,300
+329,700
+127% +$5.62M
APA icon
34
APA Corp
APA
$14B
$4.87M 0.15%
57,200
-3,400
-6% -$282K
ADP icon
35
Automatic Data Processing
ADP
$107B
$4.62M 0.14%
72,668
-5,467
-7% -$347K
FE icon
36
FirstEnergy
FE
$27.2B
$2.79M 0.08%
76,400
+52,500
+220% +$1.97M
UNP icon
37
Union Pacific
UNP
$174B
$2.47M 0.08%
31,800
-4,600
-13% -$364K
ZBH icon
38
Zimmer Biomet
ZBH
$18.7B
$2.05M 0.06%
25,750
+4,532
+21% +$357K
A icon
39
Agilent Technologies
A
$41.9B
$1.93M 0.06%
52,565
-6,850
-12% -$231K
GILD icon
40
Gilead Sciences
GILD
$168B
$1.43M 0.04%
22,700
-3,000
-12% -$179K
BMY icon
41
Bristol-Myers Squibb
BMY
$130B
$1.41M 0.04%
30,500
-300
-1% -$13.2K
CL icon
42
Colgate-Palmolive
CL
$73.6B
$1.06M 0.03%
17,800
– –
UNH icon
43
UnitedHealth
UNH
$364B
$909K 0.03%
12,700
-2,600
-17% -$186K
BRK.B icon
44
Berkshire Hathaway Class B
BRK.B
$1.09T
$851K 0.03%
7,500
– –
PEP icon
45
PepsiCo
PEP
$189B
$660K 0.02%
8,300
-200
-2% -$16.4K
PG icon
46
Procter & Gamble
PG
$335B
$571K 0.02%
7,550
– –
ABBV icon
47
AbbVie
ABBV
$440B
$419K 0.01%
9,359
-1,104,735
-99% -$49M
CSX icon
48
CSX Corp
CSX
$92.8B
$345K 0.01%
40,200
– –
HON icon
49
Honeywell
HON
$74.6B
$249K 0.01%
3,339
– –
NEE icon
50
NextEra Energy
NEE
$179B
– –
-6,207,456
Closed -$126M
1
2

Similar funds

LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
BC
Blackstart Capital New York $151M AUM 14.01% 1-Year Est. Return
JT
Jump Trading Chicago, Illinois $150M AUM 17.61% 1-Year Est. Return
SCM
Stellar Capital Management Phoenix, Arizona $147M AUM 5.91% 1-Year Est. Return
HF
Hellman & Friedman San Francisco, California $169M AUM
SMFS
Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
CCM
Castine Capital Management Boston, Massachusetts $129M AUM 23.45% 1-Year Est. Return

Stralem & Co's Q3 2013 Portfolio in Review

As of Q3 2013, Stralem & Co held 50 positions worth $3.28B, down 0.77% from $3.31B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Stralem & Co withdrew a net $180M in Q3 2013, closing 1 position and reducing 37 holdings. Its most notable exit was NextEra Energy, an estimated $126M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

Against the trend, Stralem & Co opened a new position in Amgen worth $41.3M.

  • Stralem & Co's largest Q3 2013 buy was Amgen: 368,873 shares worth $41.3M.
  • Stralem & Co added most to Walt Disney in Q3 2013, an estimated $104M increase.
  • Stralem & Co's biggest Q3 2013 reduction was AbbVie, cutting an estimated $49M.
  • Stralem & Co fully exited NextEra Energy in Q3 2013, selling an estimated $126M.
  • Stralem & Co's ten largest holdings make up 38% of its $3.28B portfolio in Q3 2013.
  • Stralem & Co opened 1 new position and closed 1 in Q3 2013.
  • Stralem & Co's portfolio value fell 0.77% quarter-over-quarter to $3.28B.

Based on Stralem & Co's 13F filing for Q3 2013, filed 17 Oct 2013.